HU0201673D0 - - Google Patents

Info

Publication number
HU0201673D0
HU0201673D0 HU0201673A HUP0201673A HU0201673D0 HU 0201673 D0 HU0201673 D0 HU 0201673D0 HU 0201673 A HU0201673 A HU 0201673A HU P0201673 A HUP0201673 A HU P0201673A HU 0201673 D0 HU0201673 D0 HU 0201673D0
Authority
HU
Hungary
Prior art keywords
alpha
piperidinylü
butylü
hydroxydiphenylmethyl
fexofenadine
Prior art date
Application number
HU0201673A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Dinamite Dipharma Dipharma S P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinamite Dipharma Dipharma S P filed Critical Dinamite Dipharma Dipharma S P
Publication of HU0201673D0 publication Critical patent/HU0201673D0/hu
Publication of HUP0201673A2 publication Critical patent/HUP0201673A2/hu
Publication of HUP0201673A3 publication Critical patent/HUP0201673A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
HU0201673A 2001-05-17 2002-05-16 Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid HUP0201673A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000260A ITRM20010260A1 (it) 2001-05-17 2001-05-17 Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz

Publications (3)

Publication Number Publication Date
HU0201673D0 true HU0201673D0 (https=) 2002-07-29
HUP0201673A2 HUP0201673A2 (hu) 2003-02-28
HUP0201673A3 HUP0201673A3 (en) 2004-07-28

Family

ID=11455529

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201673A HUP0201673A3 (en) 2001-05-17 2002-05-16 Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid

Country Status (13)

Country Link
US (1) US6815549B2 (https=)
EP (1) EP1260505B1 (https=)
JP (1) JP2003026658A (https=)
AT (1) ATE290528T1 (https=)
CA (1) CA2386452A1 (https=)
CZ (1) CZ295949B6 (https=)
DE (1) DE60203142T2 (https=)
ES (1) ES2237631T3 (https=)
HU (1) HUP0201673A3 (https=)
IT (1) ITRM20010260A1 (https=)
PL (1) PL353977A1 (https=)
PT (1) PT1260505E (https=)
SI (1) SI1260505T1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239554T1 (es) * 2002-06-10 2005-10-01 Teva Pharmaceutical Industries Ltd. Forma xvi polimorfica de hidrocloruro de fexofenadina.
EP1616861A3 (en) * 2004-06-15 2006-02-08 Dipharma S.p.A. A process for the preparation of keto compounds
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20070987A1 (it) 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
IT1395337B1 (it) * 2009-03-04 2012-09-14 Dipharma Francis Srl Procedimento per la preparazione di intermedi chetonici
WO2011158262A1 (en) * 2010-06-15 2011-12-22 Chemelectiva S.R.L. Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation
CN102079708B (zh) * 2011-02-11 2013-10-02 浙江启明药业有限公司 4-(4-卤丁酰基)-α,α-二甲基苯乙酸酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2176201T3 (es) 1992-04-10 2002-12-01 Merrell Pharma Inc Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives

Also Published As

Publication number Publication date
ITRM20010260A0 (it) 2001-05-17
EP1260505A1 (en) 2002-11-27
HUP0201673A2 (hu) 2003-02-28
SI1260505T1 (en) 2005-06-30
US20020198233A1 (en) 2002-12-26
DE60203142D1 (de) 2005-04-14
CA2386452A1 (en) 2002-11-17
ATE290528T1 (de) 2005-03-15
CZ20021726A3 (cs) 2003-01-15
ITRM20010260A1 (it) 2002-11-18
DE60203142T2 (de) 2006-04-13
PT1260505E (pt) 2005-05-31
PL353977A1 (en) 2002-11-18
EP1260505B1 (en) 2005-03-09
ES2237631T3 (es) 2005-08-01
HUP0201673A3 (en) 2004-07-28
US6815549B2 (en) 2004-11-09
JP2003026658A (ja) 2003-01-29
CZ295949B6 (cs) 2005-12-14

Similar Documents

Publication Publication Date Title
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
PL376119A1 (en) Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
HUP0400053A3 (en) New process for synthesis of 4-phenylbutyric acid
HU0201673D0 (https=)
DE60333733D1 (en) Clohexancarbonsäurederivats
AU1394802A (en) Novel process
IL150982A0 (en) Process for the preparation of donepezil
PL364369A1 (en) Process for the production of the piperidine derivative fexofenadine
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
EP1389187A4 (en) PROCESS FOR THE PREPARATION OF CEFPODOXIMIC ACID
AU2002342915A1 (en) Process for preparation of alpha-hydroxycarboxylic acid amides
AU2002233708A1 (en) Process for producing quinoline-3-carboxylic acid compound
WO2002053537A8 (en) Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
PL352455A1 (en) Method of obtaining midodrin hydrochloride
AU2002357701A1 (en) Polymorphs of fexofenadine base
EP1229029A4 (en) METHOD FOR PRODUCING A BENZYLAMINE CONNECTION
IL160694A0 (en) Intermediate compounds for the preparation of mirtazapine and the production methods thereof
EP1557407A4 (en) NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
IL160162A0 (en) Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives
IL153128A0 (en) Production method of a 2,6-dichlorophenol compound
HUP0402558A3 (en) Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives
AU2002344566A1 (en) PROCESS FOR PRODUCING Alpha-HYDROXYCARBOXYLIC ACID COMPOUND
IL150089A0 (en) Vitamin d precursors, method and intermediates

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees